» Articles » PMID: 25809977

Evaluation of the Qiagen Artus C. Difficile QS-RGQ Kit for Detection of Clostridium Difficile Toxins A and B in Clinical Stool Specimens

Overview
Specialty Microbiology
Date 2015 Mar 27
PMID 25809977
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We compared the Qiagen artus C. difficile QS-RGQ kit, a new nucleic acid amplification test for the detection of Clostridium difficile toxins in stool specimens, with the Cepheid Xpert C. difficile test. The sensitivity, specificity, positive predictive value, and negative predictive value for the Qiagen artus C. difficile QS-RGQ test were 100%, 89.5%, 60.9%, and 100%, and those for the Cepheid Xpert C. difficile test were 100%, 90%, 62.2%, and 100%, respectively.

Citing Articles

Overview of current detection methods and microRNA potential in infection screening.

Bocchetti M, Ferraro M, Melisi F, Grisolia P, Scrima M, Cossu A World J Gastroenterol. 2023; 29(22):3385-3399.

PMID: 37389232 PMC: 10303512. DOI: 10.3748/wjg.v29.i22.3385.


Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis.

Bai Y, Hao Y, Song Z, Chu W, Jin Y, Wang Y Braz J Microbiol. 2021; 52(4):1937-1949.

PMID: 34455573 PMC: 8578272. DOI: 10.1007/s42770-021-00563-7.


Laboratory Diagnostic Methods for Infection: the First Systematic Review and Meta-analysis in Korea.

Chung H, Park J, Shin B Ann Lab Med. 2020; 41(2):171-180.

PMID: 33063678 PMC: 7591293. DOI: 10.3343/alm.2021.41.2.171.


Laboratory Tests for the Diagnosis of .

Carroll K, Mizusawa M Clin Colon Rectal Surg. 2020; 33(2):73-81.

PMID: 32104159 PMC: 7042017. DOI: 10.1055/s-0039-3400476.


A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of () in Adults.

Kraft C, Parrott J, Cornish N, Rubinstein M, Weissfeld A, McNult P Clin Microbiol Rev. 2019; 32(3).

PMID: 31142497 PMC: 6589859. DOI: 10.1128/CMR.00032-18.


References
1.
Carter G, Rood J, Lyras D . The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes. 2010; 1(1):58-64. PMC: 2906822. DOI: 10.4161/gmic.1.1.10768. View

2.
Novak-Weekley S, Marlowe E, Miller J, Cumpio J, Nomura J, Vance P . Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol. 2010; 48(3):889-93. PMC: 2832460. DOI: 10.1128/JCM.01801-09. View

3.
Buchan B, Mackey T, Daly J, Alger G, Denys G, Peterson L . Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J Clin Microbiol. 2012; 50(12):3932-6. PMC: 3502949. DOI: 10.1128/JCM.02083-12. View

4.
Ylisiurua P, Koskela M, Vainio O, Tuokko H . Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins. Scand J Infect Dis. 2012; 45(1):19-25. DOI: 10.3109/00365548.2012.708780. View

5.
Kuehne S, Cartman S, Heap J, Kelly M, Cockayne A, Minton N . The role of toxin A and toxin B in Clostridium difficile infection. Nature. 2010; 467(7316):711-3. DOI: 10.1038/nature09397. View